RT Journal Article
SR Electronic
T1 Combining faecal immunochemical testing with blood test results to identify patients with symptoms at risk of colorectal cancer: a consecutive cohort of 16,604 patients tested in primary care
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.22.21263919
DO 10.1101/2021.10.22.21263919
A1 Withrow, Diana R
A1 Shine, Brian
A1 Oke, Jason
A1 Tamm, Andres
A1 James, Tim
A1 Morris, Eva
A1 Davies, Jim
A1 Harris, Steve
A1 East, James E
A1 Nicholson, Brian D
YR 2021
UL http://medrxiv.org/content/early/2021/10/26/2021.10.22.21263919.abstract
AB Objective Faecal immunochemical tests (FITs) are used to triage primary care patients with low risk colorectal cancer symptoms for referral to colonoscopy. The aim of this study was to determine whether combining FIT with routine blood test results could improve the performance of FIT in the primary care setting.Design Results of all consecutive FITs requested by primary care providers between March 2017 and December 2020 were retrieved from the Oxford University Hospitals NHS Foundation Trust. Demographic factors (age, sex), reason for referral, and results of blood tests within 90 days were also retrieved. Patients were followed up for incident colorectal cancer in linked hospital records. The sensitivity, specificity, positive and negative predictive values of FIT alone, FIT paired with blood test results, and several multivariable FIT models, were compared.Results Among 16,604 eligible patients, 139 colorectal cancers were diagnosed (0.8%). Sensitivity and specificity of FIT alone at a threshold of 10 µg Hb/g were 92.1% and 91.5% respectively. Compared to FIT alone, blood test results did not improve the performance of FIT. Pairing blood test abnormalities with FIT reduced the number of abnormal results needed to detect one cancer but increased the number of cancers missed. Multivariable models retaining FIT, sex, and mean cell volume performed similarly to FIT alone.Conclusion FIT is a highly sensitive tool for identifying higher risk individuals presenting to primary care with lower risk symptoms. Combining blood test results with FIT does not appear to lead to better discrimination for colorectal cancer than using FIT alone.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe work was supported by Cancer Research UK (CR-UK) grant number C5255/A18085 through the Cancer Research UK Oxford Centre and Oxford Centre for Early Cancer Detection (OxCODE). James East and Jim Davies are funded by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre. BDN is an NIHR Academic Clinical Lecturer and is supported by the NIHR Oxford Medtech and In-Vitro Diagnostics Co-operative. JO is part funded by the NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust. We appreciate feedback from Patrick McGuire. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR or the Department of HealthAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted as a service evaluation with registration, review and approval process within the OUH Datix governance structure (Service evaluation registration identifier: CSS-BIO-3-4730). As service evaluation, this work is not subject to the Department of Healths UK Policy Framework for Health and Social Care Research (2017). The Sponsorship and Ethics Lead within the Research Governance, Ethics and Assurance Team in the Research Support Office at the University of Oxford has confirmed that it requires neither sponsorship nor research ethics review.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData were retrieved from Oxford University Hospitals NHS Foundation Trust (OUH) and are not publicly available.